Eric Staves - Jul 1, 2024 Form 3 Insider Report for CONMED Corp (CNMD)

Role
VP Corporate Controller
Signature
/s/ Thomas Fistek for Eric Staves by Power of Attorney
Stock symbol
CNMD
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
3
Date filed
7/1/2024, 03:39 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNMD Common Stock 394 Jul 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNMD Options To Purchase Common Stock Jul 1, 2024 Common Stock 1K $78.76 Direct F1
holding CNMD Options To Purchase Common Stock Jul 1, 2024 Common Stock 4K $97.69 Direct F1
holding CNMD Options To Purchase Common Stock Jul 1, 2024 Common Stock 4.5K $122.55 Direct F1
holding CNMD Options To Purchase Common Stock Jul 1, 2024 Common Stock 4.75K $144.55 Direct F1
holding CNMD Options To Purchase Common Stock Jul 1, 2024 Common Stock 6K $96.16 Direct F1
holding CNMD Options To Purchase Common Stock Jul 1, 2024 Common Stock 6K $79.95 Direct F1
holding CNMD Rsus (restricted Stock Units) Jul 1, 2024 Common Stock 250 $0.00 Direct F2
holding CNMD Rsus (restricted Stock Units) Jul 1, 2024 Common Stock 3K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.